Gene Editing Study demonstrates long-term safety and clinical benefit of combination therapy for cystic fibrosis Posted on March 15, 2023 by Editorial Staff Patients with cystic fibrosis (CF) face difficulty breathing and a decline in lung function and are at risk of early death. CF is an inherited condition that results in thick mucus build-up, persistent infection and inflammation in the lungs. Share on FacebookTweetFollow us Editorial Staff Effectiveness of SPARK Resilience program during COVID-19 pandemic Researchers uncover new clue as to how “whole genome doubling” drives cancer